Literature DB >> 4981666

Relationship between chemical structure and platelet-aggregation activity of prostaglandins.

J Kloeze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4981666     DOI： 10.1016/0005-2760(69)90001-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  28 in total

1.  The effect of pulmonary metabolites of prostaglandins E1, E2 and F2alpha on ADP-induced aggregation of human and rabbit platelets [proceedings].

Authors:  J Westwick
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

2.  Biochemical mechanisms in 5-hydroxytryptamine-induced human platelet aggregation.

Authors:  F de Clerck; B Xhonneux; R van de Wiele
Journal:  Agents Actions       Date:  1985-12

3.  Modulation of the random migration of human platelets.

Authors:  F H Valone; K F Austen; E J Goetzl
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

4.  Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction.

Authors:  J B Smith; C Ingerman; J J Kocsis; M J Silver
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

5.  Oral antigastric acid secretory activity of synthetic prostaglandin analogues (9-oxoprostanoic acids).

Authors:  W Lippmann
Journal:  Experientia       Date:  1973-08-15

Review 6.  [Clinical use of prostaglandins].

Authors:  A J Vergroesen; P Gans; J J Gottenbos; F ten Hoor
Journal:  Klin Wochenschr       Date:  1971-08-15

7.  The synthesis of prostaglandins in human platelets.

Authors:  J Clausen; K C Srivastava
Journal:  Lipids       Date:  1972-04       Impact factor: 1.880

8.  Inhibition of prostaglandin biosynthesis by 7-oxa- and 5-oxa-prostaglandin analogues.

Authors:  R G McDonald-Gibson; J D Flack; P W Ramwell
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

9.  Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency.

Authors:  Vivek Gupta; Nilesh Gupta; Imam H Shaik; Reza Mehvar; Eva Nozik-Grayck; Ivan F McMurtry; Masahiko Oka; Masanobu Komatsu; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2013-03-26       Impact factor: 4.939

10.  Prostaglandin uptake and metabolism by the perfused rat liver.

Authors:  W Dawson; S J Jessup; W McDonald-Gibson; P W Ramwell; J E Shaw
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.